Search Results 271-280 of 10606 for Latent TB infection

1. Transition To KPL-387 Monotherapy Dosing & Administration Study - Mayo Clinic

   ... latent tuberculosis (TB) prior to screening. ... TB infection or active infection. * Has a history ... infection, chest infection, sinusitis, or skin/soft tissue ...

2. A Study to Find RNA Markers that Describe the Underlying Inflammatory Process and Can Help Direct Therapy - Mayo Clinic

   ... infection. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

3. A Study To Assess The Efficacy And Safety Of Induction And Maintenance Therapy With Afimkibart (RO7790121) In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

   * Has evidence of active tuberculosis (TB), latent TB not successfully treated (per local guidance) or inadequately treated TB * Has received protocol ...

4. A Phase 2 Proof Of Concept Study To Evaluate The Efficacy And Safety Of Daxdilimab In Participants With Dermatomyositis (DM) Or Anti-synthetase Inflammatory Myositis (ASIM) - Mayo Clinic

   latent TB according to local guidelines. 10. Any severe herpes virus family infection (including Epstein-Barr virus, cytomegalovirus [CMV]) at any time ...

5. Efficacy And Safety Of Tozorakimab In Patients Hospitalised For Viral Lung Infection Requiring Supplemental Oxygen (TILIA) - Mayo Clinic

   The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on ...

6. Chronic bladder infection: Is there a cure? - Mayo Clinic

   A bladder infection is a type of urinary tract infection (UTI). You might have chronic, or recurrent, bladder infections if you have two or more bladder ...

7. A Study To Evaluate TAK-018 For Prevention Of The Recurrence Of Postoperative Crohn's Disease (CD) - Mayo Clinic

   Has active or latent tuberculosis, regardless of treatment history, as evidenced by any of the following: history of tuberculosis; OR ... infection (evident by ...

8. Preventing, treating COVID-19 infection - Mayo Clinic News Network

   ... infection, according to data provided by the Centers for Disease Control and Prevention. "The No. 1 strategy to prevent infection of the virus from ...

9. Cutaneous B-cell lymphoma - Symptoms and causes - Mayo Clinic

   Primary cutaneous marginal zone B-cell lymphoma has been linked to Borrelia burgdorferi infection in some European countries. Exposure to foreign substances in ...

10. Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...